Compare $BIXT vs $BRTX | Chartloom

Compare

$BIXT vs $BRTX

Bioxytran Inc · BioRestorative Therapies Inc

BIXT

Bioxytran Inc

BRTX

BioRestorative Therapies Inc

Compare $BIXT vs $BRTX

Comparing Bioxytran Inc and BioRestorative Therapies Inc

BIXTBioxytran Inc

BRTXBioRestorative Therapies Inc

BIXTBioxytran Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-68.2%

52W performance

-67.7%

FCF yield

-34.2%

BRTXBioRestorative Therapies Inc

Market cap

$49M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-8.5%

YTD performance

-92.2%

52W performance

-94.2%

FCF yield

-24.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BIXT

BRTX

Detailed metrics comparison

BIXT

Bioxytran Inc

BRTX

BioRestorative Therapies Inc

Market Cap

BIXT$3M

BRTX$49M

Enterprise Value

BIXT$4M

BRTX$46M

Price

BIXT$0.02

BRTX$1.91

P/E Ratio

BIXTN/A

BRTXN/A

P/S Ratio

BIXT18.76x

BRTX135.98x

EV/Sales

BIXT19.26x

BRTX127.28x

EV/EBITDA

BIXT121.99x

BRTX0.00x

P/B Ratio

BIXT4.86x

BRTX0.98x

P/FCF Ratio

BIXTN/A

BRTXN/A

EV/FCF

BIXT-4.08x

BRTX-3.83x

PEG Ratio

BIXTN/A

BRTXN/A

Forward P/E (NTM)

BIXTN/A

BRTXN/A

Forward P/S (NTM)

BIXTN/A

BRTXN/A

Revenue (TTM)

BIXT$0

BRTX$358K

Revenue Growth (YoY)

BIXTN/A

BRTX-8.5%

Forward Rev Growth

BIXT0.0%

BRTX64.6%

Gross Margin (TTM)

BIXT47.4%

BRTX92.1%

Operating Margin (TTM)

BIXT0.0%

BRTX0.0%

EBITDA Margin (TTM)

BIXT0.0%

BRTX-3915.8%

Net Margin (TTM)

BIXT0.0%

BRTX-3089.3%

FCF Margin (TTM)

BIXTN/A

BRTX-3324.3%

Net Income (TTM)

BIXT$-3M

BRTX$-11M

FCF (TTM)

BIXT$-893K

BRTX$-12M

EPS (TTM)

BIXT-$0.03

BRTX-$12.47

ROE (TTM)

BIXT-755.0%

BRTX-42384.0%

ROA (TTM)

BIXT-79248.0%

BRTX-19330.0%

ROIC (TTM)

BIXT-612.0%

BRTX-42384.0%

Cash

BIXT$177K

BRTX$3M

Debt

BIXT$1M

BRTX$0

Net Cash/Debt

BIXT$-1M

BRTX$3M

Current Ratio (TTM)

BIXT0.03x

BRTX2.35x

Quick Ratio (TTM)

BIXT0.03x

BRTX2.23x

Debt/Equity (TTM)

BIXT0.20x

BRTX0.00x

Debt/Assets (TTM)

BIXT0.0%

BRTX0.0%

Interest Coverage (TTM)

BIXTN/A

BRTXN/A

Net Debt/EBITDA (TTM)

BIXT0.00x

BRTX0.00x

Beta

BIXT2.80

BRTX0.80

52W Performance

BIXT-67.7%

BRTX-94.2%

YTD Performance

BIXT-68.2%

BRTX-92.2%

% from 52W High

BIXT-75.9%

BRTX-94.5%

% from 52W Low

BIXT14.5%

BRTX9.1%

Asset Turnover (TTM)

BIXT0.50x

BRTX0.06x

FCF Yield (TTM)

BIXT-34.2%

BRTX-24.4%

Earnings Yield (TTM)

BIXT-133.6%

BRTX-22.7%

Dividend Yield (TTM)

BIXTN/A

BRTXN/A

Rule of 40

BIXT0.0

BRTX-3,332.8

EV/GP/RG

BIXTN/A

BRTX2.12

Ticker research

View BIXT research View BRTX research

Metric	BIXT Bioxytran Inc	BRTX BioRestorative Therapies Inc
Market & Valuation
Market Cap	$3M	$49M
Enterprise Value	$4M	$46M
Price	$0.02	$1.91
P/E Ratio	N/A	N/A
P/S Ratio	18.76x	135.98x
EV/Sales	19.26x	127.28x
EV/EBITDA	121.99x	0.00x
P/B Ratio	4.86x	0.98x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.08x	-3.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$358K
Revenue Growth (YoY)	N/A	-8.5%
Forward Rev Growth	0.0%	64.6%
Profitability
Gross Margin (TTM)	47.4%	92.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3915.8%
Net Margin (TTM)	0.0%	-3089.3%
FCF Margin (TTM)	N/A	-3324.3%
Net Income (TTM)	$-3M	$-11M
FCF (TTM)	$-893K	$-12M
EPS (TTM)	-$0.03	-$12.47
ROE (TTM)	-755.0%	-42384.0%
ROA (TTM)	-79248.0%	-19330.0%
ROIC (TTM)	-612.0%	-42384.0%
Financial Health
Cash	$177K	$3M
Debt	$1M	$0
Net Cash/Debt	$-1M	$3M
Current Ratio (TTM)	0.03x	2.35x
Quick Ratio (TTM)	0.03x	2.23x
Debt/Equity (TTM)	0.20x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.80	0.80
52W Performance	-67.7%	-94.2%
YTD Performance	-68.2%	-92.2%
% from 52W High	-75.9%	-94.5%
% from 52W Low	14.5%	9.1%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	0.06x
FCF Yield (TTM)	-34.2%	-24.4%
Earnings Yield (TTM)	-133.6%	-22.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3,332.8
EV/GP/RG	N/A	2.12
Ticker research	View BIXT research	View BRTX research

Valuation

P/S Ratio

BIXT

18.76x

BRTX

135.98x

EV/FCF

BIXT

-4.08x

BRTX

-3.83x

Growth & revenue

Revenue Growth TTM

BRTX

-8.5%

Forward Revenue Growth

BRTX

64.6%

BIXT

0.0%

Profitability & performance

Gross Margin

BRTX

92.1%

BIXT

47.4%

ROE

BIXT

-755.0%

BRTX

-42384.0%

FCF Yield %

BRTX

-24.4%

BIXT

-34.2%

52-Week Performance

BIXT

-67.7%

BRTX

-94.2%

Detailed metrics comparison

BIXT

Bioxytran Inc

BRTX

BioRestorative Therapies Inc

Market Cap

BIXT$3M

BRTX$49M

Enterprise Value

BIXT$4M

BRTX$46M

Price

BIXT$0.02

BRTX$1.91

P/E Ratio

BIXTN/A

BRTXN/A

P/S Ratio

BIXT18.76x

BRTX135.98x

EV/Sales

BIXT19.26x

BRTX127.28x

EV/EBITDA

BIXT121.99x

BRTX0.00x

P/B Ratio

BIXT4.86x

BRTX0.98x

P/FCF Ratio

BIXTN/A

BRTXN/A

EV/FCF

BIXT-4.08x

BRTX-3.83x

PEG Ratio

BIXTN/A

BRTXN/A

Forward P/E (NTM)

BIXTN/A

BRTXN/A

Forward P/S (NTM)

BIXTN/A

BRTXN/A

Revenue (TTM)

BIXT$0

BRTX$358K

Revenue Growth (YoY)

BIXTN/A

BRTX-8.5%

Forward Rev Growth

BIXT0.0%

BRTX64.6%

Gross Margin (TTM)

BIXT47.4%

BRTX92.1%

Operating Margin (TTM)

BIXT0.0%

BRTX0.0%

EBITDA Margin (TTM)

BIXT0.0%

BRTX-3915.8%

Net Margin (TTM)

BIXT0.0%

BRTX-3089.3%

FCF Margin (TTM)

BIXTN/A

BRTX-3324.3%

Net Income (TTM)

BIXT$-3M

BRTX$-11M

FCF (TTM)

BIXT$-893K

BRTX$-12M

EPS (TTM)

BIXT-$0.03

BRTX-$12.47

ROE (TTM)

BIXT-755.0%

BRTX-42384.0%

ROA (TTM)

BIXT-79248.0%

BRTX-19330.0%

ROIC (TTM)

BIXT-612.0%

BRTX-42384.0%

Cash

BIXT$177K

BRTX$3M

Debt

BIXT$1M

BRTX$0

Net Cash/Debt

BIXT$-1M

BRTX$3M

Current Ratio (TTM)

BIXT0.03x

BRTX2.35x

Quick Ratio (TTM)

BIXT0.03x

BRTX2.23x

Debt/Equity (TTM)

BIXT0.20x

BRTX0.00x

Debt/Assets (TTM)

BIXT0.0%

BRTX0.0%

Interest Coverage (TTM)

BIXTN/A

BRTXN/A

Net Debt/EBITDA (TTM)

BIXT0.00x

BRTX0.00x

Beta

BIXT2.80

BRTX0.80

52W Performance

BIXT-67.7%

BRTX-94.2%

YTD Performance

BIXT-68.2%

BRTX-92.2%

% from 52W High

BIXT-75.9%

BRTX-94.5%

% from 52W Low

BIXT14.5%

BRTX9.1%

Asset Turnover (TTM)

BIXT0.50x

BRTX0.06x

FCF Yield (TTM)

BIXT-34.2%

BRTX-24.4%

Earnings Yield (TTM)

BIXT-133.6%

BRTX-22.7%

Dividend Yield (TTM)

BIXTN/A

BRTXN/A

Rule of 40

BIXT0.0

BRTX-3,332.8

EV/GP/RG

BIXTN/A

BRTX2.12

Ticker research

View BIXT research View BRTX research

Metric	BIXT Bioxytran Inc	BRTX BioRestorative Therapies Inc
Market & Valuation
Market Cap	$3M	$49M
Enterprise Value	$4M	$46M
Price	$0.02	$1.91
P/E Ratio	N/A	N/A
P/S Ratio	18.76x	135.98x
EV/Sales	19.26x	127.28x
EV/EBITDA	121.99x	0.00x
P/B Ratio	4.86x	0.98x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.08x	-3.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$358K
Revenue Growth (YoY)	N/A	-8.5%
Forward Rev Growth	0.0%	64.6%
Profitability
Gross Margin (TTM)	47.4%	92.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3915.8%
Net Margin (TTM)	0.0%	-3089.3%
FCF Margin (TTM)	N/A	-3324.3%
Net Income (TTM)	$-3M	$-11M
FCF (TTM)	$-893K	$-12M
EPS (TTM)	-$0.03	-$12.47
ROE (TTM)	-755.0%	-42384.0%
ROA (TTM)	-79248.0%	-19330.0%
ROIC (TTM)	-612.0%	-42384.0%
Financial Health
Cash	$177K	$3M
Debt	$1M	$0
Net Cash/Debt	$-1M	$3M
Current Ratio (TTM)	0.03x	2.35x
Quick Ratio (TTM)	0.03x	2.23x
Debt/Equity (TTM)	0.20x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.80	0.80
52W Performance	-67.7%	-94.2%
YTD Performance	-68.2%	-92.2%
% from 52W High	-75.9%	-94.5%
% from 52W Low	14.5%	9.1%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	0.06x
FCF Yield (TTM)	-34.2%	-24.4%
Earnings Yield (TTM)	-133.6%	-22.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3,332.8
EV/GP/RG	N/A	2.12
Ticker research	View BIXT research	View BRTX research